Companies are exploring alternative treatment pathways and have several novel classes of drugs for COPD in development (Table 1), including inhibitors of leukotriene B 4 receptors and chemokine ...
In 2019, COPD was responsible for ... all designed to act on specific molecular pathways and tailored to selected patient populations. Beyond drug treatments, several non-pharmacological ...
Medically reviewed by Daniel More, MDOxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and ...